Sugi Predict

Sugi Predict / Targets / ATP6V1G1

ATP6V1G1

V-type proton ATPase subunit G 1 · O75348 · ATP6V1G1 on Sugi Atlas →

0 patent compounds predicted against ATP6V1G1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ATP6V1G1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast Cancer PHASE3COMPLETED
Applying Proton Pump Inhibitor to Prevent and Treat Acute Fluctuating Hearing Loss in Patients With SLC26A4 Mutation PHASE2/PHASE3UNKNOWN
Copper Histidine Therapy for Menkes Diseases PHASE1/PHASE2COMPLETED
Natural History Study of ATP1A3-related Disease nanUNKNOWN
Phenotypic and Genotypic Studies in Congenital and Early Onset Ataxias nanCOMPLETED
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome nanRECRUITING
Prescreening Study to Identify Potential Wilson Disease Participants for Gene-Editing Clinical Trial nanACTIVE_NOT_RECRUITING
Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts nanCOMPLETED
Natural History of GACI With or Without ARHR2 or PXE nanUNKNOWN
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
Biomarkers in the Etiology of Idiopathic Intracranial Hypertension nanUNKNOWN
Gastrointestinal Dysfunction in Children Affected With Mitochondrial Disorders nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Genetic Analysis of Hereditary Disorders of Hearing and Balance nanCOMPLETED
Hepatic Substrate Flux Rates in Type 2 Diabetes nanACTIVE_NOT_RECRUITING
GDF-15 as a Biomarker for Mitochondrial Disease nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Correlation Between Peri-implantitis and Assumptions of Medications nanCOMPLETED
Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease nanRECRUITING
Pediatric Cardiomyopathy Mutation Analysis nanRECRUITING
Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy nanNOT_YET_RECRUITING
Study of Resting and Exercising Body Functioning in Freeman-Sheldon Syndrome and Related Conditions nanWITHDRAWN
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma nanRECRUITING
PCD New Gene Discovery nanCOMPLETED
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants nanRECRUITING
Oxalate and Citrate in Humans - Response to Citrate nanRECRUITING
Genetics of Primary Ciliary Dyskinesia nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a ATP6V1G1 binder may also engage these)

ProteinNameSimilarity
P79251 — 1.000 P79251 →
Q9CR51 — 1.000 Q9CR51 →
Q5XGW0 — 0.997 Q5XGW0 →
P91303 — 0.997 P91303 →
Q25532 — 0.996 Q25532 →
Q5TM18 — 0.992 Q5TM18 →
Q9XZH6 — 0.992 Q9XZH6 →
A4QNE9 — 0.991 A4QNE9 →
Q96LB4 — 0.990 Q96LB4 →
O95670 — 0.990 O95670 →
Q617N0 — 0.989 Q617N0 →
Q5WR09 — 0.988 Q5WR09 →
Q1XHY9 — 0.988 Q1XHY9 →
P48836 — 0.988 P48836 →
Q9WTT4 — 0.987 Q9WTT4 →
Q9TSV6 — 0.987 Q9TSV6 →
Q8BMC1 — 0.986 Q8BMC1 →
Q0VCV6 — 0.986 Q0VCV6 →
Q862Z6 — 0.986 Q862Z6 →
Q9SZH0 — 0.985 Q9SZH0 →
Q54Z13 — 0.984 Q54Z13 →
O74174 — 0.984 O74174 →
O13687 — 0.978 O13687 →
O00780 — 0.972 O00780 →
O74760 — 0.972 O74760 →
Q01278 — 0.972 Q01278 →
P22203 — 0.971 P22203 →
P78713 — 0.971 P78713 →
A0LLG2 — 0.971 A0LLG2 →
Q95X44 — 0.969 Q95X44 →